
DermaSensor
by DermaSensor, Inc.
Categories
DiagnosticsCancer DetectionComputer VisionClinical Decision Support
Description
A handheld device that non-invasively assesses skin lesions for cancer risk using optical spectroscopy and AI.
Summary
DermaSensor is an FDA-cleared, handheld device designed to help clinicians assess the risk of skin cancer in suspicious skin lesions. It uses a combination of optical spectroscopy and artificial intelligence to analyze lesions and provide immediate risk assessment results. This tool aims to enhance clinical confidence, support timely referrals, and improve patient outcomes by offering an objective, non-invasive method for skin cancer evaluation.
Use Cases
- A family medicine practitioner uses DermaSensor to assess a suspicious mole on a patient's arm, aiding in the decision whether to refer to dermatology.
- A walk-in clinic utilizes DermaSensor for a quick risk assessment of skin lesions, streamlining the process of skin cancer detection.
Platforms
Web
Regulatory Status
FDA clearedAPI Available
NoAdded to Directory
8/23/2025Target Customer
Clinician